US Patent Issued to University of Sharjah on Oct. 27 for "Design, synthesis and mechanisms of anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives" (Emirati Inventors)

Posted On: 2026-10-27

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,270, issued on Oct. 27, was assigned to University of Sharjah (Sharjah, United Arab Emirates).

"Design, synthesis and mechanisms of anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives" was invented by Hajjaj H.M. Abdu-Allah (Sharjah, United Arab Emirates), Wafaa S. Ramadan (Sharjah, United Arab Emirates), Maha Mohamed Saber-Ayad (Sharjah, United Arab Emirates), Rifat Hamoudi (Sharjah, United Arab Emirates), Samrein Ahmed (Sharjah, United Arab Emirates), Thenmozhi Venkatachalam (Sharjah, United Arab Emirates), Shirin Hafezi (Sharjah, United Arab Emirates), Abdel-Nasser El-Shorbagi (Sharjah, United Arab Emirates), Hamadeh Tarazi (Sharjah, United A...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to University of Sharjah on Oct. 27 for "Design, synthesis and mechanisms of anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives" (Emirati Inventors)